We are developing a cutting edge device platform to scale global manufacturing capacity, enabling cost effective and safe cell therapies for all patients.

Facts about cell therapy

85%

complete remission in r/r ALL patients
after a cell therapy treatment

Source

44%

still cancer free, four years after a single infusion of a cell therapy

Source

<1%

of all blood cancer patients receive
a cell therapy

320K

price in EUR of a cell therapy
Kymriah, Germany 2020

Vision

Motivation

Cell Therapy transformed cancer treatment. Sarcura will transform cell therapy manufacturing.

Daniela Buchmayr, MBA
CEO

Sarcura's Solution

Technology

Miniaturization

Silicon and microfluidic structures enable processing on cellular level

Automation

Industrial automation increases product quality and scalability

Integration

Integrated process and quality control facilitates real-time process information

Modularity

Functional modules allow individual process designs and conceptional flexibility

Sarcura closed a 2.5 m€ seed round

Feb. 2021 / Company, Technology

Sarcura and imec enter a collaboration agreement

Mar. 2021 / Company

Sarcura received a 1.5 m€ research grant from FFG

Supported by

Partners

"You have to aim high enough to change something. Sarcura is not an usual „evolutionary" startup. Instead, they see the big picture ahead of them and know exactly which steps to take to make it a reality."

Liesbet Lagae
Program Director Life Science Technologies

„Cell therapies have demonstrated enormous potential and the demand is growing. Sarcura's technology has the potential to enable an entire industry to grow and prosper, with benefits to all stakeholders - especially patients.“

Marta Gaia Zanchi
Managing Partner / Nina capital

Cell therapy can cure cancer.
Bring it to life.

Join the team

Is your area of expertise a fit for Sarcura?
Talk to us!

We are developing a cutting edge device platform to scale global manufacturing capacity, enabling cost effective and safe cell therapies for all patients.

85%

44%

<1%

320K

Cell Therapy transformed cancer treatment. Sarcura will transform cell therapy manufacturing.

Miniaturization

Automation

Integration

Modularity

Sarcura closed a 2.5 m€ seed round

Sarcura and imec enter a collaboration agreement

Sarcura received a 1.5 m€ research grant from FFG

"You have to aim high enough to change something. Sarcura is not an usual „evolutionary" startup. Instead, they see the big picture ahead of them and know exactly which steps to take to make it a reality."

„Cell therapies have demonstrated enormous potential and the demand is growing. Sarcura's technology has the potential to enable an entire industry to grow and prosper, with benefits to all stakeholders - especially patients.“

Is your area of expertise a fit for Sarcura?
Talk to us!

Cell therapy can cure cancer. Bring it to life.

Join the team

Is your area of expertise a fit for Sarcura? Talk to us!

We are developing a cutting edge device platform to scale global manufacturing capacity, enabling cost effective and safe cell therapies for all patients.

85%

44%

<1%

320K

Cell Therapy transformed cancer treatment. Sarcura will transform cell therapy manufacturing.

Miniaturization

Automation

Integration

Modularity

Sarcura closed a 2.5 m€ seed round

Sarcura and imec enter a collaboration agreement

Sarcura received a 1.5 m€ research grant from FFG

"You have to aim high enough to change something. Sarcura is not an usual „evolutionary" startup. Instead, they see the big picture ahead of them and know exactly which steps to take to make it a reality."

„Cell therapies have demonstrated enormous potential and the demand is growing. Sarcura's technology has the potential to enable an entire industry to grow and prosper, with benefits to all stakeholders - especially patients.“

Is your area of expertise a fit for Sarcura? Talk to us!

Cell therapy can cure cancer.
Bring it to life.

Is your area of expertise a fit for Sarcura?
Talk to us!

Is your area of expertise a fit for Sarcura?
Talk to us!